Braun DJ, Powell DK, McLouth CJ, Roy SM, et al. Therapeutic treatment with the anti-inflammatory drug candidate MW151 may partially reduce memory impairment and normalizes hippocampal metabolic markers in a mouse model of comorbid amyloid and vascular pathology. PLoS One 2022;17:e0262474.
PMID: 35081152